《British Journal Of Haematology》雜志的最新年發文量為367篇。
這表明該刊在每年都會精選并發表一定數量的高質量文章，以保持其在血液學領域的學術影響力。
該刊聚焦于醫學-血液學領域的前沿研究，致力于推動該領域新技術和新知識的傳播與應用。同時它積極鼓勵研究人員詳細發表其高質量的實驗研究和理論成果。
該刊的平均審稿周期約為 約1月 。
British Journal Of Haematology 雜志發文統計
文章名稱引用次數
- The use of viscoelastic haemostatic assays in the management of major bleeding A British Society for Haematology Guideline40
- Cobomarsen, an oligonucleotide inhibitor of miR- co-ordinately regulates multiple survival pathways to reduce cellular proliferation and survival in cutaneous T-cell lymphoma39
- Cytokine release syndrome and neurotoxicity after CD19 chimeric antigen receptor-modified (CAR-) T cell therapy35
- Eculizumab in paroxysmal nocturnal haemoglobinuria and atypical haemolytic uraemic syndrome: 10-year pharmacovigilance analysis31
- A phase 2 study of modified lenalidomide, bortezomib and dexamethasone in transplant-ineligible multiple myeloma30
- Haemostasis and innate immunity - a complementary relationship: A review of the intricate relationship between coagulation and complement pathways25
- Advances in understanding the pathogenesis of acquired aplastic anaemia23
- The full spectrum of Castleman disease: 273 patients studied over 20 years22
- Incidence of and risk factors for major haemorrhage in patients treated with ibrutinib: An integrated analysis21
- How I manage patients with relapsed/refractory diffuse large B cell lymphoma21
